TAE Technologies is pleased to announce the appointment of William Coaker as the company’s first Chief Investment Officer. Bill comes to TAE with over two decades of experience in investment, most recently as Chief Investment Officer for the San Francisco Employees Retirement System (SFERS), a $34 billion public pension plan. Bill’s leadership and vision will play a central role in TAE’s next phase of growth.

TAE Technologies, the world’s largest private fusion energy company, has announced a landmark fusion technology milestone by producing stable plasma at 50M+ degrees Celsius in a proprietary compact reactor design that can scale to competitive fusion-generated power.

TAE Life Sciences (TLS), a biological-targeting radiation therapy company developing next-generation boron neutron capture therapy solutions (BNCT), announced the launch of an innovative in-house boron delivery drug development program supported by an influx of $30M in funding. The initial phase of the B-round funds comes from a consortium of investors including ARTIS Ventures, who led the company’s initial funding in 2018.

TAE Technologies, Inc., the world’s largest private fusion energy company, has been awarded three funding partnerships for continued fusion research through the U.S. Department of Energy’s (DOE) Office of Fusion Energy Science’s (FES) Innovation Network for Fusion Energy (INFUSE) program.

TAE Technologies is pleased to announce the re-appointment of Marco Arese to its Board of Directors. Arese brings a wealth of entrepreneurial experience activating global capital, scaling international business, and cultivating renewable energy opportunities, all of which he will leverage on behalf of the company as it continues commercialization of its transformational technologies.